Mental and Behavioral DisordersNCT07286305
Media and Mental Health
A study testing ThinkHumanTV in people with Mental and Behavioral Disorders and Mental Resilience, run by University of Arizona at 1 site in United States.
Trial summary
This study's goal is to find if using the ThinkHumanTV program during 6 weekly sessions of watching Netflix or Disney series or movies for 90 minutes, together with 4 - 8 members of the Whole Health Center and EpiCenter and a discussion leader, improves the wellbeing of the group participants. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Mental and Behavioral Disorders, Mental Resilience, Emotional Awareness
- What is being tested?
- ThinkHumanTV
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteUnited States
- Study dates
- 6 Feb 2026to Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age ≥ 18years old
- Recipient of treatment at WHC for at least 6 months.
- English speaking
Who cannot join
- Actively manic
- Actively suicidal
- Has not been dependent on drugs or alcohol for at least 30 days
- Deemed to be at significant risk of being dangerous to self or others by the patients' WHC physician
- Deemed inappropriate based on judgment of WHC physician informed by WHC staff
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Arizona
Tucson, Arizona, 85724
Karen Weihs, MD, 520-626-8940, weihs@psychiatry.arizona.edu
About this study
This study's goal is to find if using the ThinkHumanTV program during 6 weekly sessions of watching Netflix or Disney series or movies for 90 minutes, together with 4 - 8 members of the Whole Health Center and EpiCenter and a discussion leader, improves the wellbeing of the group participants.
Read the detailed description
This study's goal is to find out whether 6 weekly sessions of watching certain TV series or movies in a group setting, augmented through education from ThinkHuman TV about emotions and coping with emotions embedded in the process of watching (with a discussion leader), will improve the resilience of mental health patients enrolled in a long-term community mental health center. This will be tested by comparing ThinkHuman TV augmented movies with watching moving in a group without ThinkHuman TV educational activities to see if there is better improvement in resilience and well-being of the group participants who have THinkHuman included as compared to those who do not.
- Conditions
- Mental and Behavioral Disorders, Mental Resilience, Emotional Awareness, Emotional Development
- Being tested
- ThinkHumanTV
- Keywords
- Healthy Adults, Emotional Awareness
- Medical subject headings
- Mental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ThinkHumanTVDevice
Emotional Education Program
| Study group | Role | What they receive |
|---|---|---|
| Media Only | No intervention | Not described |
| ThinkHuman TV | Active comparator | Not described Receives: Device: ThinkHumanTV |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline in emotional awareness/intelligence.
Assessed using The Emotional Regulation Questionnaire
- Score: Minimum = 0 Maximum = 70 (higher better outcome) Assessed using Emotional Self-Efficacy Scale
- Score: Minimum = 32 Maximum = 160 (higher better outcome)
Measured: 3 month interventional period
Change from baseline in anxiety.
Assessed using The Overall Anxiety Severity and Impairment Scale (OASIS)
-Score: Minimum = 0 Maximum = 20 (higher worse outcome)
Measured: 3 month interventional period
Change from baseline in depression symptoms.
Assessed using the Center for Epidemiologic Studies Depression scale (CES-D)
-Score: Minimum = 0 Maximum = 30 (higher worse outcome)
Measured: 3 month interventional period
Secondary outcomes (1)
Change from baseline in quality of life.
Assessed by Q-LES-Q-SF questionnaire
-Score: Minimum = 14 Maximum = 70 (higher better outcome)
Measured: After 3 month interventional period
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Dec 2025
- Study start6 Feb 2026
- Primary completionAug 2026 (estimated)
- Study completionNov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mental and Behavioral DisordersStudies of the same condition, open and under way.
- More trials run by University of ArizonaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomized into either a control group (media only), or an interventional group (ThinkHuman TV). There is a 50/50 chance of being assigned to each group.
- Masking
- None (open label)
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Arizona
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07286305
- Sponsor's protocol ID
- STUDY00005488
- Status last verified
- Feb 2026
- First submitted
- 10 Dec 2025
- Last updated
- 12 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- Yes: A limited data set (including all study data with identifiers other than date removed) will be shared by secure file transfer to consultants at Affectifi, Inc and will be available by request from the study investigators upon request through secure file transfer. Only general summary information will be shared with the study funder.
Study at a glance
From the registry record, last updated by the sponsor on 12 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Media and Mental Health
- ClinicalTrials.gov ID
- NCT07286305
- Acronym / sponsor ID
- STUDY00005488
- Conditions
- Mental and Behavioral Disorders, Mental Resilience, Emotional Awareness, Emotional Development
- Keywords
- Healthy Adults, Emotional Awareness
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- University of ArizonaUniversity, hospital or other
- Study start
- 6 Feb 2026 (actual)
- Primary completion
- Aug 2026 (estimated)
- Study completion
- Nov 2026 (estimated)
- First posted
- 16 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study's goal is to find if using the ThinkHumanTV program during 6 weekly sessions of watching Netflix or Disney series or movies for 90 minutes, together with 4 - 8 members of the Whole Health Center and EpiCenter and a discussion leader, improves the wellbeing of the group participants.
Detailed description
This study's goal is to find out whether 6 weekly sessions of watching certain TV series or movies in a group setting, augmented through education from ThinkHuman TV about emotions and coping with emotions embedded in the process of watching (with a discussion leader), will improve the resilience of mental health patients enrolled in a long-term community mental health center. This will be tested by comparing ThinkHuman TV augmented movies with watching moving in a group without ThinkHuman TV educational activities to see if there is better improvement in resilience and well-being of the group participants who have THinkHuman included as compared to those who do not.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants will be randomized into either a control group (media only), or an interventional group (ThinkHuman TV). There is a 50/50 chance of being assigned to each group.
| Arm | Type | Receives |
|---|---|---|
| Media Only | No intervention | – |
| ThinkHuman TV | Active comparator | Device: ThinkHumanTV |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Age ≥ 18years old
- Recipient of treatment at WHC for at least 6 months.
- English speaking
Key exclusion criteria (5 listed)
- Actively manic
- Actively suicidal
- Has not been dependent on drugs or alcohol for at least 30 days
- Deemed to be at significant risk of being dangerous to self or others by the patients' WHC physician
- Deemed inappropriate based on judgment of WHC physician informed by WHC staff
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ThinkHumanTVEmotional Education Program | Device | ThinkHuman TV |
Primary outcome
Change from baseline in emotional awareness/intelligence.
Time frame: 3 month interventional period
Assessed using The Emotional Regulation Questionnaire * Score: Minimum = 0 Maximum = 70 (higher better outcome) Assessed using Emotional Self-Efficacy Scale * Score: Minimum = 32 Maximum = 160 (higher better outcome)
Change from baseline in anxiety.
Time frame: 3 month interventional period
Assessed using The Overall Anxiety Severity and Impairment Scale (OASIS) -Score: Minimum = 0 Maximum = 20 (higher worse outcome)
Change from baseline in depression symptoms.
Time frame: 3 month interventional period
Assessed using the Center for Epidemiologic Studies Depression scale (CES-D) -Score: Minimum = 0 Maximum = 30 (higher worse outcome)
1 secondary outcome
Change from baseline in quality of life.
Time frame: After 3 month interventional period
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Feb 2026.
- Individual participant dataSharing planned: Yes. A limited data set (including all study data with identifiers other than date removed) will be shared by secure file transfer to consultants at Affectifi, Inc and will be available by request from the study investigators upon request through secure file transfer. Only general summary information will be shared with the study funder.
Related trials for Mental and Behavioral Disorders
Recruiting
Inspiratory Muscle Training and Diaphragmatic Breathing in GAD
Generalized Anxiety Disorder (GAD)
RecruitingPhase 3
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Depressive Disorder, Major
Recruiting
Rural Veteran and Care Partner Walking Program
Mild Cognitive Impairment (MCI)
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Alzheimer's Disease
RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Depressive Disorder, Major
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ThinkHumanTV in people with Mental and Behavioral Disorders and Mental Resilience, run by University of Arizona at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 12 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Brent Gary ((520) 626-8000, bgary@arizona.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline in emotional awareness/intelligence. (time frame: 3 month interventional period). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2026.